Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study: A Study to Evaluate the Safety and Efficacy of Transcatheter Closure of Patent Foramen Ovale for Relief of Migraine Headaches

NCT04100135 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT04100135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04100135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study: A Study to Evaluate the Safety and Efficacy of Transcatheter Closure of Patent Foramen Ovale for Relief of Migraine Headaches
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Terminated
Start date
February 5, 2021
Completion date
August 15, 2024
Enrollment
7 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, patent foramen ovale, pfo - patent foramen ovale